Tech Company Financing Transactions

Marcadia Biotech Funding Round

Marcadia Biotech closed a $15 million Series A venture capital round on 5/15/2007. Investors included 5AM Ventures, Frazier Healthcare Partners and Twilight Venture Partners.

Transaction Overview

Company Name
Marcadia Biotech
Announced On
5/15/2007
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors

5AM Ventures (Lead Investor) (Carin Rollins)

Frazier Healthcare Partners (Lead Investor) (Patrick Heron)

Twilight Venture Partners

Proceeds Purpose
"This funding will allow us to significantly advance our discovery and development efforts," said Fritz French, CEO. "This includes the company's first compound in development, a glucagon analog that will be supplied in an injector pen, making it ready for quick use in emergency treatment of hypoglycemia."

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
11711 N. Meridian Street 300
Carmel, IN 46032
USA
Phone
(317) 566-2266
Website
www.marcadiabiotech.com
Email Address
[email protected]
Overview
The company is developing a device for the emergency treatment of hypoglycemia.
Profile
Marcadia Biotech LinkedIn Company Profile
Social Media
Marcadia Biotech Company Twitter Account
Company News
Marcadia Biotech News
Facebook
Marcadia Biotech on Facebook
YouTube
Marcadia Biotech on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Fritz French
  Fritz French LinkedIn Profile  Fritz French Twitter Account  Fritz French News  Fritz French on Facebook
Chief Financial Officer
Kristin Sherman
  Kristin Sherman LinkedIn Profile  Kristin Sherman Twitter Account  Kristin Sherman News  Kristin Sherman on Facebook
Chief Scientific Officer
Richard DiMarchi
  Richard DiMarchi LinkedIn Profile  Richard DiMarchi Twitter Account  Richard DiMarchi News  Richard DiMarchi on Facebook
Vice President
Louis Vignati
  Louis Vignati LinkedIn Profile  Louis Vignati Twitter Account  Louis Vignati News  Louis Vignati on Facebook
VP - Bus. Development
Kent Hawryluk
  Kent Hawryluk LinkedIn Profile  Kent Hawryluk Twitter Account  Kent Hawryluk News  Kent Hawryluk on Facebook
VP - R & D
Jaswant Gidda
  Jaswant Gidda LinkedIn Profile  Jaswant Gidda Twitter Account  Jaswant Gidda News  Jaswant Gidda on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/15/2007: Venomix venture capital transaction
Next: 5/15/2007: Finsbury Solutions Limited venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.